Works matching AU Cortot, Alexis

Results: 42

Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.

Published in:

2017

By:

Kuchcinski, Grégory;
Le Rhun, Emilie;
Cortot, Alexis;
Drumez, Elodie;
Duhal, Romain;
Lalisse, Maxime;
Dumont, Julien;
Lopes, Renaud;
Pruvo, Jean-Pierre;
Leclerc, Xavier;
Delmaire, Christine;
Kuchcinski, Grégory;
Cortot, Alexis B

Publication type:

journal article

Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy.

Published in:

European Radiology, 2013, v. 23, n. 8, p. 2127, doi. 10.1007/s00330-013-2821-2

By:

Tacelli, Nunzia;
Santangelo, Teresa;
Scherpereel, Arnaud;
Duhamel, Alain;
Deken, Valérie;
Klotz, Ernst;
Cortot, Alexis;
Lafitte, Jean-Jacques;
Wallyn, Frédéric;
Remy, Jacques;
Remy-Jardin, Martine

Publication type:

Article

Response to Capmatinib in a MET Fusion-positive Cholangiocarcinoma.

Published in:

Oncologist, 2023, v. 28, n. 1, p. 80, doi. 10.1093/oncolo/oyac194

By:

Turpin, Anthony;
Descarpentries, Clotilde;
Grégoire, Valérie;
Farchi, Olivier;
Cortot, Alexis B;
Jamme, Philippe

Publication type:

Article

Can Studies on Early Palliative Care Be Harmful to Patient Well Being?

Published in:

Journal of Palliative Medicine, 2019, v. 22, n. 12, p. 1488, doi. 10.1089/jpm.2019.0333

By:

Touzet, Licia;
Dhalluin, Xavier;
Scherpereel, Arnaud;
Prod'homme, Chloé;
Cortot, Alexis;
Gamblin, Vincent

Publication type:

Article

Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221099399

By:

Bilger, Geoffroy;
Toffart, Anne-Claire;
Darrason, Marie;
Duruisseaux, Michaël;
Ulmer, Lucie;
Wang, Pascal;
Leprieur, Etienne Giroux;
Girard, Nicolas;
Massiani, Marie Ange;
Bore, Paul;
Descourt, Renaud;
Pinsolle, Julian;
Valery, Solene;
Monnet, Isabelle;
Swalduz, Aurélie;
Tissot, Claire;
Fournel, Pierre;
Baranzelli, Anne;
Cortot, Alexis B.;
Decroisette, Chantal

Publication type:

Article

PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.

Published in:

Molecular Oncology, 2015, v. 9, n. 9, p. 1852, doi. 10.1016/j.molonc.2015.07.001

By:

Kherrouche, Zoulika;
Monte, Didier;
Werkmeister, Elisabeth;
Stoven, Luc;
De Launoit, Yvan;
Cortot, Alexis B.;
Tulasne, David;
Chotteau-Lelievre, Anne

Publication type:

Article

Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study.

Published in:

2018

By:

Olivier, Cecile;
Grosbois, Jean-Marie;
Cortot, Alexis B.;
Peres, Sophie;
Heron, Christophe;
Delourme, Julie;
Gierczynski, Marianne;
Hoorelbeke, Anne;
Scherpereel, Arnaud;
Le Rouzic, Olivier

Publication type:

journal article

Unmet supportive care needs of caregivers according to medical settings of cancer patients: a cross-sectional study.

Published in:

Supportive Care in Cancer, 2022, v. 30, n. 11, p. 9411, doi. 10.1007/s00520-022-07379-7

By:

Christophe, Véronique;
Anota, Amelie;
Vanlemmens, Laurence;
Cortot, Alexis;
Ceban, Tatiana;
Piessen, Guillaume;
Charton, Emilie;
Baudry, Anne-Sophie

Publication type:

Article

Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC.

Published in:

Cancer Medicine, 2018, v. 7, n. 11, p. 5505, doi. 10.1002/cam4.1825

By:

Lesueur, Paul;
Escande, Alexandre;
Thariat, Juliette;
Vauléon, Enora;
Monnet, Isabelle;
Cortot, Alexis;
Lerouge, Delphine;
Danhier, Serge;
Dô, Pascal;
Dubos‐Arvis, Catherine;
Chouaïd, Christos;
Gervais, Radj

Publication type:

Article

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER.

Published in:

Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.578756

By:

Goldman, Jonathan W.;
Mazieres, Julien;
Barlesi, Fabrice;
Dragnev, Konstantin H.;
Koczywas, Marianna;
Göskel, Tuncay;
Cortot, Alexis B.;
Girard, Nicolas;
Wesseler, Claas;
Bischoff, Helge;
Nadal, Ernest;
Park, Keunchil;
Lu, Shun;
Taus, Alvaro;
Cobo, Manuel;
Estrem, Shawn T.;
Wijayawardana, Sameera R.;
Turner, Kellie;
Oakley III, Gerard Joseph;
Hurt, Karla C.

Publication type:

Article

Dose-Seeking Phase I Trials for Currently Approved Molecular-Targeted Therapies in the USA: The Dose-Limiting Toxicity Definition Issue.

Published in:

Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 143, doi. 10.1007/s40290-016-0138-6

By:

Kotecki, Nuria;
Awada, Ahmad;
Bonneterre, Jacques;
Hebbar, Mohamed;
Adenis, Antoine;
Cortot, Alexis;
Cousin, Sophie;
Clisant, Stéphanie;
Duhamel, Alain;
Penel, Nicolas

Publication type:

Article

Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the CBL ubiquitin ligase binding site.

Published in:

FEBS Letters, 2023, v. 597, n. 18, p. 2301, doi. 10.1002/1873-3468.14702

By:

Fernandes, Marie;
Paget, Sonia;
Kherrouche, Zoulika;
Truong, Marie‐José;
Vinchent, Audrey;
Meneboo, Jean‐Pascal;
Sebda, Shéhérazade;
Werkmeister, Elisabeth;
Descarpentries, Clotilde;
Figeac, Martin;
Cortot, Alexis B.;
Tulasne, David

Publication type:

Article

Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers.

Published in:

Targeted Oncology, 2023, v. 18, n. 6, p. 927, doi. 10.1007/s11523-023-01009-w

By:

Marchal, Marine;
Leroy, Vincent;
Behal, Hélène;
Dansin, Eric;
Paris, Nicolas;
Bordier, Soraya;
Humez, Sarah;
Escande, Fabienne;
Gauvain, Clément;
Cortot, Alexis B.

Publication type:

Article

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study.

Published in:

Targeted Oncology, 2023, v. 18, n. 4, p. 585, doi. 10.1007/s11523-023-00976-4

By:

Babey, Hélène;
Jamme, Philippe;
Curcio, Hubert;
Assié, Jean Baptiste;
Veillon, Remi;
Doubre, Hélène;
Pérol, Maurice;
Guisier, Florian;
Huchot, Eric;
Decroisette, Chantal;
Falchero, Lionel;
Corre, Romain;
Cortot, Alexis;
Chouaïd, Christos;
Descourt, Renaud

Publication type:

Article

Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors.

Published in:

OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2024.2374954

By:

Bredon, Marius;
Danne, Camille;
Pham, Hang Phuong;
Ruffié, Pauline;
Bessede, Alban;
Rolhion, Nathalie;
Creusot, Laura;
Brot, Loic;
Alonso, Iria;
Langella, Philippe;
Derosa, Lisa;
Cortot, Alexis B.;
Routy, Bertrand;
Zitvogel, Laurence;
Segata, Nicola;
Sokol, Harry

Publication type:

Article

Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.

Published in:

OncoImmunology, 2020, v. 9, n. 1, p. 1, doi. 10.1080/2162402X.2020.1722022

By:

Scanvion, Quentin;
Béné, Johana;
Gautier, Sophie;
Grandvuillemin, Aurélie;
Le Beller, Christine;
Chenaf, Chouki;
Etienne, Nicolas;
Brousseau, Solenn;
Cortot, Alexis B.;
Mortier, Laurent;
Staumont-Sallé, Delphine;
Morschhauser, Franck;
Forestier, Alexandra;
Groh, Matthieu;
Launay, David;
Hachulla, Eric;
Labalette, Myriam;
Kahn, Jean-Emmanuel;
Lefèvre, Guillaume

Publication type:

Article

Rien ne sert de courir, il faut partir à point; Leçons apprises d'une intervention psychologique en oncologie: de l'importance de conduire des études pilotes et/ou de faisabilité dans les interventions complexes.

Published in:

Psycho-Oncologie, 2023, v. 17, n. 3, p. 201, doi. 10.32604/po.2023.044910

By:

Lelorain, Sophie;
Duprez, Christelle;
Caton, Laura;
Nguyen, Marie-Mai;
d'Almeida, Gildas;
Piessen, Guillaume;
Cortot, Alexis

Publication type:

Article

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer.

Published in:

Investigational New Drugs, 2020, v. 38, n. 5, p. 1588, doi. 10.1007/s10637-020-00930-5

By:

Yamamoto, Nobuyuki;
Hayashi, Hidetoshi;
Planchard, David;
Morán, Teresa;
Gregorc, Vanesa;
Dowell, Jonathan;
Sakai, Hiroshi;
Yoh, Kiyotaka;
Nishio, Makoto;
Cortot, Alexis B.;
Benhadji, Karim A.;
Soni, Nital;
Huang, Jinhong;
Makris, Lukas;
Cedres, Susana

Publication type:

Article

Improved Survival Outcomes in Patients With MET Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.

Published in:

Clinical Lung Cancer, 2023, v. 24, n. 7, p. 641, doi. 10.1016/j.cllc.2023.08.011

By:

Wolf, Jurgen;
Souquet, Pierre-Jean;
Koichi Goto;
Cortot, Alexis;
Baik, Christina;
Heist, Rebecca;
Tae Min Kim;
Ji-Youn Han;
Neal, Joel W.;
Mansfield, Aaron S.;
Gilloteau, Isabelle;
Nwana, Ngozi;
Lynch, Maeve Waldron;
Davis, Keith L.;
Giovannini, Monica;
Awad, Mark M.

Publication type:

Article

MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes.

Published in:

Clinical Lung Cancer, 2023, v. 24, n. 6, p. 483, doi. 10.1016/j.cllc.2023.06.008

By:

Mazieres, Julien;
Vioix, Helene;
Pfeiffer, Boris M.;
Campden, Rhiannon I.;
Zhiyuan Chen;
Heeg, Bart;
Cortot, Alexis B.

Publication type:

Article

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 4, p. 320, doi. 10.1016/j.cllc.2022.03.002

By:

Veillon, Remi;
Hiroshi Sakai;
Xiuning Le;
Felip, Enriqueta;
Cortot, Alexis B.;
Smit, Egbert E.;
Keunchil Park;
Griesinger, Frank;
Britschgi, Christian;
Yi-Long Wu;
Melosky, Barbara;
Baijal, Shobhit;
de Castro Jr., Gilberto;
Sedova, Michaela;
Berghoff, Karin;
Otto, Gordon;
Paik, Paul K.

Publication type:

Article

Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical Review.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 3, p. 195, doi. 10.1016/j.cllc.2022.01.003

By:

Cortot, Alexis;
Xiuning Le;
Smit, Egbert;
Viteri, Santiago;
Terufumi Kato;
Hiroshi Sakai;
Keunchil Park;
Camidge, D. Ross;
Berghoff, Karin;
Vlassak, Soetkin;
Paik, Paul K.

Publication type:

Article

A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non–Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 Mutation.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e131, doi. 10.1016/j.cllc.2021.06.002

By:

Pinquie, François;
Cortot, Alexis B.;
Chevalier, Louise-Marie;
Morel, Alain;
Sandrini, Jérémy;
Guguen, Camille;
Morvan, Benjamin;
Molinier, Olivier

Publication type:

Article

Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial.

Published in:

2020

By:

Bennouna, Jaafar;
Girard, Nicolas;
Audigier-Valette, Clarisse;
le Thuaut, Aurélie;
Gervais, Radj;
Masson, Philippe;
Marcq, Marie;
Molinier, Olivier;
Cortot, Alexis;
Debieuvre, Didier;
Cadranel, Jacques;
Lena, Hervé;
Moro-Sibilot, Denis;
Chouaid, Christos;
Mennecier, Bertrand;
Urban, Thierry;
Sagan, Christine;
Perrier, Ludivine;
Barlesi, Fabrice;
Denis, Marc G.

Publication type:

journal article

Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice.

Published in:

2019

By:

Jamme, Philippe;
Descarpentries, Clotilde;
Gervais, Radj;
Dansin, Eric;
Wislez, Marie;
Grégoire, Valérie;
Richard, Nicolas;
Baldacci, Simon;
Rabbe, Nathalie;
Kyheng, Maeva;
Kherrouche, Zoulika;
Escande, Fabienne;
Copin, Marie Christine;
Cortot, Alexis B.

Publication type:

journal article

Current and Former Smokers: Who Wants To Be Screened?

Published in:

2018

By:

Couraud, Sébastien;
Greillier, Laurent;
Brignoli-Guibaudet, Lysel;
Lhomel, Christine;
Viguier, Jérôme;
Morère, Jean F.;
Eisinger, François;
Cortot, Alexis B.

Publication type:

journal article

Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas.

Published in:

2014

By:

Cortot, Alexis B;
Younes, Mohamad;
Martel-Planche, Ghislaine;
Guibert, Benoit;
Isaac, Sylvie;
Souquet, Pierre-Jean;
Commo, Frédéric;
Girard, Philippe;
Fouret, Pierre;
Brambilla, Elisabeth;
Hainaut, Pierre;
Soria, Jean-Charles

Publication type:

journal article

Mutation of TP53 and Alteration of p14<sup>arf</sup> Expression in EGFR- and KRAS-Mutated Lung Adenocarcinomas.

Published in:

Clinical Lung Cancer, 2014, v. 15, n. 2, p. 124, doi. 10.1016/j.cllc.2013.08.003

By:

Cortot, Alexis B.;
Younes, Mohamad;
Martel-Planche, Ghislaine;
Guibert, Benoit;
Isaac, Sylvie;
Souquet, Pierre-Jean;
Commo, Frédéric;
Girard, Philippe;
Fouret, Pierre;
Brambilla, Elisabeth;
Hainaut, Pierre;
Soria, Jean-Charles

Publication type:

Article

Patterns of Treatment and Real‐World Outcomes of Patients With Non‐small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study.

Published in:

Cancer Medicine, 2025, v. 14, n. 3, p. 1, doi. 10.1002/cam4.70369

By:

Liu, Geoffrey;
Nyaw, Shi Feng;
Mok, Tony S. K.;
Curcio, Hubert;
Cortot, Alexis B.;
Kam, Tsz Yeung;
Descourt, Renaud;
Chik, Yin Kwan;
Cheema, Parneet;
Gwinnutt, James M.;
Churchill, Eric N.;
Nyborn, Justin;
Curran, Eileen;
Savell, Alexandra;
Yin, Yu;
Chong, Katie;
Tanaka‐Chambers, Yuka;
Kretz, Julian;
Cadranel, Jacques

Publication type:

Article

EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti-EGFR treatment of a rare lung malignancy.

Published in:

International Journal of Cancer, 2009, v. 125, n. 10, p. 2479, doi. 10.1002/ijc.24610

By:

Italiano, Antoine;
Cortot, Alexis B.;
Ilie, Marius;
Martel-Planche, Ghyslaine;
Fabas, Thibault;
Pop, Daniel;
Mouroux, Jérôme;
Hofman, Veronique;
Hofman, Paul;
Pedeutour, Florence

Publication type:

Article

Daily Caffeine Consumption May Increase the Risk of Acute Kidney Injury Related to Platinum-Salt Chemotherapy in Thoracic Cancer Patients: A Translational Study.

Published in:

Nutrients, 2024, v. 16, n. 6, p. 889, doi. 10.3390/nu16060889

By:

Hamroun, Aghiles;
Decaestecker, Antoine;
Larrue, Romain;
Fellah, Sandy;
Blum, David;
Van der Hauwaert, Cynthia;
Scherpereel, Arnaud;
Cortot, Alexis;
Lenain, Rémi;
Maanaoui, Mehdi;
Pottier, Nicolas;
Cauffiez, Christelle;
Glowacki, François

Publication type:

Article

Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251318160

By:

Roboubi, Amytis;
Wasielewski, Eric;
Bordier, Soraya;
Turlotte, Amélie;
Pavaut, Geoffrey;
Scherpereel, Arnaud;
Cortot, Alexis;
Gauvain, Clément

Publication type:

Article

Pursuit or discontinuation of anti-PD1 after 2 years of treatment in long-term responder patients with non-small cell lung cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231195600

By:

Ardin, Camille;
Humez, Sarah;
Leroy, Vincent;
Ampere, Alexandre;
Bordier, Soraya;
Escande, Fabienne;
Turlotte, Amélie;
Stoven, Luc;
Nunes, David;
Cortot, Alexis;
Gauvain, Clément

Publication type:

Article

ctDNA Dynamics, Prognostic Markers, and Mechanisms of Resistance in Tepotinib-treated MET exon 14 (METex14) Skipping NSCLC in the VISION Trial.

Published in:

Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 352

By:

Xiuning Le;
Garassino, Marina Chiara;
Myung-Ju Ahn;
Felip, Enriqueta;
Cortot, Alexis B.;
Hiroshi Sakai;
Mazières, Julien;
Thomas, Michael;
Viteri, Santiago;
Conte, Pierfranco;
Chih-Hsin Yang, James;
Iams, Wade Thomas;
Griesinger, Frank;
Braggio, Danielle;
Stroh, Christopher;
Juraeva, Dilafruz;
Wang, Danyi;
Johne, Andreas;
Paik, Paul K.

Publication type:

Article

Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study.

Published in:

Cancers, 2022, v. 14, n. 7, p. 1751, doi. 10.3390/cancers14071751

By:

Descourt, Renaud;
Pérol, Maurice;
Rousseau-Bussac, Gaëlle;
Planchard, David;
Mennecier, Bertrand;
Wislez, Marie;
Cadranel, Jacques;
Cortot, Alexis Benjamin;
Guisier, Florian;
Galland, Loïck;
Do, Pascal;
Schott, Roland;
Dansin, Éric;
Arrondeau, Jennifer;
Auliac, Jean-Bernard;
Geier, Margaux;
Chouaïd, Christos

Publication type:

Article

Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study.

Published in:

Cancers, 2022, v. 14, n. 6, p. 1498, doi. 10.3390/cancers14061498

By:

Assié, Jean-Baptiste;
Crépin, Florian;
Grolleau, Emmanuel;
Canellas, Anthony;
Geier, Margaux;
Grébert-Manuardi, Aude;
Akkache, Nabila;
Renault, Aldo;
Hauss, Pierre-Alexandre;
Sabatini, Marielle;
Bonnefoy, Valentine;
Cortot, Alexis;
Wislez, Marie;
Gauvain, Clément;
Chouaïd, Christos;
Scherpereel, Arnaud;
Monnet, Isabelle

Publication type:

Article

Histology... For Want of Anything Better?

Published in:

Oncology (08909091), 2009, v. 23, n. 13, p. 1140

By:

Cortot, Alexis B.;
Jänne, Pasi A.

Publication type:

Article

Prospective validation obtained in a similar group of patients and with similar high throughput biological tests failed to confirm signatures for prediction of response to chemotherapy and survival in advanced NSCLC: a prospective study from the European Lung Cancer Working Party

Published in:

Frontiers in Oncology, 2015, v. 5, p. 1, doi. 10.3389/fonc.2014.00386

By:

Berghmans, Thierry;
CsToth, Ingrid;
Meert, Anne-Pascale;
Dernies, Tiffany;
Leclercq, Nathalie;
Sculier, Jean-Paul;
Mascaux, Céline;
Willems, Luc;
Ameye, Lieveke;
Paesmans, Marianne;
Lafitte, Jean-Jacques;
Cortot, Alexis;
Scherpereel, Arnaud;
Colinet, Benoît;
Holbrechts, Stéphane;
Lecomte, Jacques;
Richez, Michel;
Tulippe, Christian

Publication type:

Article

Perception of Lung Cancer Risk: Impact of Smoking Status and Nicotine Dependence.

Published in:

Current Oncology Reports, 2018, v. 20, p. 1, doi. 10.1007/s11912-017-0650-1

By:

Greillier, Laurent;
Cortot, Alexis B.;
Viguier, Jérôme;
Brignoli-Guibaudet, Lysel;
Lhomel, Christine;
Eisinger, François;
Morère, Jean-François;
Couraud, Sébastien

Publication type:

Article

ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?

Published in:

Expert Review of Anticancer Therapy, 2015, v. 15, n. 2, p. 225, doi. 10.1586/14737140.2014.986103

By:

Girard, Nicolas;
Audigier-Valette, Clarisse;
Cortot, Alexis B;
Mennecier, Bertrand;
Debieuvre, Didier;
Planchard, David;
Zalcman, Gérard;
Moro-Sibilot, Denis;
Cadranel, Jacques;
Barlési, Fabrice

Publication type:

Article

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M.

Published in:

Nature, 2009, v. 462, n. 7276, p. 1070, doi. 10.1038/nature08622

By:

Wenjun Zhou;
Ercan, Dalia;
Liang Chen;
Cai-Hong Yun;
Li, Danan;
Capelletti, Marzia;
Cortot, Alexis B.;
Chirieac, Lucian;
Iacob, Roxana E.;
Padera, Robert;
Engen, John R.;
Kwok-Kin Wong;
Eck, Michael J.;
Gray, Nathanael S.;
Jänne, Pasi A.

Publication type:

Article

Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers.

Published in:

2017

By:

Cortot, Alexis B.;
Kherrouche, Zoulika;
Descarpentries, Clotilde;
Wislez, Marie;
Baldacci, Simon;
Furlan, Alessandro;
Tulasne, David

Publication type:

journal article